Cart
sales@molnova.com
CFTR corrector 8
CAS No. 1918142-35-4
CFTR corrector 8( —— )
Catalog No. M35744 CAS No. 1918142-35-4
CFTR corrector 8 is a highly effective modulator of the cystic fibrosis transmembrane conductance regulator (CFTR).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 112 | Get Quote |
|
| 5MG | 170 | Get Quote |
|
| 10MG | 264 | Get Quote |
|
| 25MG | 517 | Get Quote |
|
| 50MG | 812 | Get Quote |
|
| 100MG | 1305 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCFTR corrector 8
-
NoteResearch use only, not for human use.
-
Brief DescriptionCFTR corrector 8 is a highly effective modulator of the cystic fibrosis transmembrane conductance regulator (CFTR).
-
DescriptionCFTR corrector 8 is a potent CFTR modulator. CFTR can be used in the research of cystic fibrosis.
-
In VitroCFTR corrector 8 (compound 12) shows EC50s of 1 μM (CSE-HRP assay) and 3 μM (HBE-TECC assay) .CFTR corrector 8 exhibits hepatocyte clearance rate of 1250/775 L/hr/kg (human/rat).
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetCFTR
-
RecptorCFTR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1918142-35-4
-
Formula Weight539.52
-
Molecular FormulaC29H27F2NO7
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 110 mg/mL (203.88 mM; Ultrasonic )
-
SMILESCOc1ccc2[C@H](C[C@H](Oc2c1)c1ccc(OC)c(OC)c1)NC(=O)C1(CC1)c1ccc2OC(F)(F)Oc2c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wang X, et al. Discovery of 4-[(2R,4R)-4-({[1-(2,2-Difluoro-1,3-benzodioxol-5-yl)cyclopropyl]carbonyl}amino)-7-(difluoromethoxy)-3,4-dihydro-2H-chromen-2-yl]benzoic Acid (ABBV/GLPG-2222), a Potent Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Corrector for the Treatment of Cystic Fibrosis. J Med Chem. 2018 Feb 22;61(4):1436-1449. ?
molnova catalog
related products
-
SRI-37240
SRI-37240 is a potent inhibitor of premature termination codons (PTCs) with read-across activity that induces a prolonged pause at the termination codon and inhibits PTCs associated with cystic fibrosis.
-
VX661
VX-661 is a second F508del CFTR corrector and is believed to help CFTR protein reach the cell surface. Phase 2.
-
VX-809
VX-809 (Lumacaftor, VRT 826809) is a potent CFTR corrector that increases F508del-CFTR-mediated chloride transport amd improves F508del-CFTR maturation in FRT cells with EC50 of 0.1 and 0.5 uM, respectively.
